Persistent Opioid Use High in Head, Neck Cancer Patients

FRIDAY, Jan. 11, 2019 — Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery. Jessica D. McDermott, M.D., from the University of Colorado Anschutz School of Medicine in Aurora, and colleagues used data from the Surveillance, Epidemiology […]

Read more

Role of PCSK9 inhibitors in high risk patients with dyslipidemia

Familial hypercholesterolemia (FH) is an inherited autosomal dominant disorder which is characterized by substantially increased Low-Density Lipoprotein Cholesterol (LDL-C) levels. Timely reduction of LDL-C is of paramount importance to ameliorate the risk for CV disease as patients with FH have a significantly higher risk for Cardiovascular (CV) events. Pro-protein Convertase Subtilisin/Kexin type 9 (PCSK9) inhibitors have emerged as a very […]

Read more

High cost of re-operation after breast-conserving surgery

A small number of women require re-operation after breast-conserving surgery (BCS) for breast cancer, if the surgical margins are not free from cancer. A new BJS (British Journal of Surgery) analysis reveals the expense of re-operation. If re-operation rates can be minimized, there may be considerable efficiency savings. Using data from relevant published studies, the authors found the median hospital […]

Read more

Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine

Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to “conventional medicine”. Researchers from the Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) at the University of Technology Sydney (UTS) […]

Read more

High risk alternative tobacco products disproportionately sold in low-income communities

Retailers in minority and low-income communities are more likely to sell and advertise the most inexpensive and risky alternative tobacco products, according to a new study conducted at Columbia University Mailman School of Public Health. Potentially less risky, non-combusted products such as smokeless tobacco and e-cigarettes are more accessible in higher income and predominantly White neighborhoods. Until this study, little […]

Read more

High Cost Has Over 1 in 4 Diabetics Cutting Back on Insulin

MONDAY, Dec. 3, 2018 — More than one-quarter of people with diabetes have skimped on needed insulin because of the drug’s soaring price tag, according to a new small study. Surveying nearly 200 Americans with type 1 or type 2 diabetes, researchers found 26 percent had underused insulin because of cost. But insulin isn’t a drug you can safely ration, […]

Read more

One in four patients say they’ve skimped on insulin because of high cost

For patients with diabetes, insulin is a life-saving medicine and an essential component of diabetes management, yet in the past decade alone, the out-of-pocket costs for insulin have doubled in the United States. One-quarter of patients with type 1 or 2 diabetes have reported using less insulin than prescribed due to these high costs, Yale researchers write in JAMA Internal […]

Read more

Diabetes patients with high deductible health plans experience delays in seeking care

Research from the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute finds that a population of people with diabetes who were switched to high-deductible health plans had associated delays in care for dangerous blood vessel diseases. The study, “High-deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes,” appears in the […]

Read more

Treatment for moderately high blood pressure best saved for those at high risk

An observational study of patients with mild hypertension has found no evidence to support recent US guideline recommendations that encourage doctors to offer treatment to patients with low-risk mild hypertension. Researchers from the University of Oxford, Cambridge University and the University of Birmingham looked at the routinely collected medical records of more than 38,000 patients in the UK over a […]

Read more

Gun Violence Among U.S. Youth Has High Price Tag

MONDAY, Oct. 29, 2018 — Treating gunshot wounds in American children and teens costs roughly $270 million a year in hospital bills, researchers report. “In our study, we found that for every 100,000 teenagers and children arriving to the emergency department, 11 come for a gun-related injury,” said study author Dr. Faiz Gani. He is a research fellow at Johns […]

Read more